Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on: February 20,2025 0

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on:February 20,2025 0

A step towards personalized immunotherapy: MIRO device replicates tumors, environments and interactions

Updated on: April 01,2025 0

A step towards personalized immunotherapy: MIRO device replicates tumors, environments and interactions

Updated on:April 01,2025 0

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

Updated on: March 27,2025 0

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

Updated on:March 27,2025 0

Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells

Updated on: April 01,2025 0

Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells

Updated on:April 01,2025 0

Microglia reprogramming offers novel strategy to combat melanoma brain metastases

Updated on: April 01,2025 0

Microglia reprogramming offers novel strategy to combat melanoma brain metastases

Updated on:April 01,2025 0

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on: December 21,2024 0

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on:December 21,2024 0

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Updated on: January 17,2025 0

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Updated on:January 17,2025 0

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on: January 23,2025 0

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on:January 23,2025 0

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on: January 22,2025 0

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on:January 22,2025 0

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Updated on: December 20,2024 0

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Updated on:December 20,2024 0

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on: January 22,2025 0

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on:January 22,2025 0

3D bioprinting technology could lead to personalized gastric cancer treatment

Updated on: April 07,2025 0

3D bioprinting technology could lead to personalized gastric cancer treatment

Updated on:April 07,2025 0